Entrada Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireDec 18 20:00

PepGen Stock Craters 35% on FDA Clinical Hold

Seeking AlphaDec 16 22:56

Are Strong Financial Prospects The Force That Is Driving The Momentum In Entrada Therapeutics, Inc.'s NASDAQ:TRDA) Stock?

Simply Wall StDec 13 18:00

Roth MKM Starts 'Overlooked' Entrada Therapeutics With Buy Rating

Yahoo FinanceDec 7 18:25

Roth Initiates Entrada Therapeutics at Buy

MT NewswiresDec 6 21:08

H.C. Wainwright Maintains Entrada Therapeutics(TRDA.US) With Buy Rating, Raises Target Price to $29

Futu NewsDec 6 18:33 · Ratings